Cytokinetics reported $93K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Arca Biopharma ABIO:US USD 14K 0
Bayer BAYN:GR EUR 2.52B 0
Biogen BIIB:US USD 100K 0
Brainstorm Cell Therapeutics BCLI:US USD 12K 0
Capricor Therapeutics CAPR:US USD 25K 1000
Cytokinetics CYTK:US USD 93K 8K
Eisai 4523:JP JPY 44.99B 0
Exelixis EXEL:US USD 323K 1000
Halozyme Therapeutics HALO:US USD 135K 3K
Intra Cellular Therapies ITCI:US USD 9K 0
Novartis NOVN:VX USD 890M 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Roche Holding ROG:VX 107M 53M